Advertisement
Screener

AUTONOMIX MEDICAL, INC. (AMIX) Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted

2.8 / 5 stars · 68/120 Roast Me

AUTONOMIX MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted

AUTONOMIX MEDICAL, INC. (AMIX) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 15.07 million shares for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-27.

Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2026-05-27

  • AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2026-03-31 was 0.00 shares.
  • AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-12-31 was 13.50M shares.
  • AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-09-30 was 1.57M shares.
  • AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2025-06-30 was 0.00 shares.
  • AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2026 was 15.07M shares, a 492.73% increase from fiscal 2025.
  • AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2025 was 2.54M shares, a 51.37% increase from fiscal 2024.
  • AUTONOMIX MEDICAL, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2024 was 1.68M shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month
2026-03-310.00 shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-27
13.50M shares
derived: sum of 2 quarters · filed 2026-05-27
15.07M shares
derived: sum of 3 quarters · filed 2026-05-27
15.07M shares
10-K · filed 2026-05-27
2025-12-3113.50M shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11
15.07M shares
derived: sum of 2 quarters · filed 2026-02-11
15.07M shares
10-Q · filed 2026-02-11
2025-09-301.57M shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-12
1.57M shares
10-Q · filed 2025-11-12
2025-06-300.00 shares
10-Q · filed 2025-08-13
2025-03-312.54M shares
10-K · filed 2026-05-27
2024-06-300.00 shares
10-Q · filed 2024-08-13
2024-03-311.68M shares
10-K · filed 2024-05-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Beyond Air, Inc. (XAIR)United States$0.003B-0.01
Vivos Therapeutics, Inc. (VVOS)United States$0.003B-0.26
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
NEXGEL, INC. (NXGL)United States$0.002B
INVO Fertility, Inc. (IVF)United States$0.002B-0.71
Catheter Precision, Inc. (VTAK)United States$0.002B-0.23